Valuation: Lead Data Inc.

Market Cap 539M 16.84M 14.54M 13.67M 12.43M 23.37M 1.61B 23.75M 160M 62.61M 806M 63.22M 61.85M 2.68B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.75M 15.33M 14.4M 13.1M 24.63M 1.7B 25.04M 169M 65.99M 850M 66.63M 65.19M 2.82B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 16/08/2022
Director of Finance/CFO - 09/06/2022
Corporate Officer/Principal - 09/06/2022
Director TitleAgeSince
Director/Board Member - 09/06/2019
Chairman - 16/08/2022
Director/Board Member - 09/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+13.33% 16.84M
-0.39%+1.86%+32.33%+18.38% 10B
+3.64%+6.43% - - 1.53B
+0.23%-3.85%+8.79%-4.22% 1.36B
+0.63%-0.36%-5.65%-17.08% 1.07B
-0.40%+0.48%+74.13%+17.79% 735M
-0.65%+3.99%-19.06%-66.31% 632M
0.00%+1.28%-13.25%-9.20% 420M
+0.48%+1.44%+98.35%+153.15% 412M
+0.78%+2.37%-2.56%+21.48% 224M
Average -0.55%-1.56%+19.23%+14.15% 1.64B
Weighted average by Cap. +0.13%+1.18%+27.31%+13.14%

Financials

2024 2025
Net sales 15.47M 483K 417K 392K 357K 671K 46.22M 682K 4.6M 1.8M 23.15M 1.81M 1.78M 76.92M 111M 3.46M 2.99M 2.81M 2.55M 4.8M 331M 4.88M 32.9M 12.86M 166M 12.99M 12.71M 550M
Net income -134M -4.18M -3.61M -3.39M -3.09M -5.8M -400M -5.9M -39.76M -15.55M -200M -15.7M -15.36M -665M -44.02M -1.38M -1.19M -1.12M -1.02M -1.91M -132M -1.94M -13.08M -5.12M -65.88M -5.17M -5.05M -219M
Net Debt -16.95M -530K -458K -430K -391K -735K -50.67M -747K -5.04M -1.97M -25.37M -1.99M -1.95M -84.31M 29.12M 910K 786K 739K 672K 1.26M 87.02M 1.28M 8.65M 3.38M 43.58M 3.42M 3.34M 145M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock